SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-17-114795
Filing Date
2017-04-07
Accepted
2017-04-07 07:04:12
Documents
18
Effectiveness Date
2017-04-07

Document Format Files

Seq Description Document Type Size
1 DEFM14A d307733ddefm14a.htm DEFM14A 3243729
2 GRAPHIC g307733g06g54.jpg GRAPHIC 65198
3 GRAPHIC g307733g06m54.jpg GRAPHIC 78701
4 GRAPHIC g307733g11y77.jpg GRAPHIC 26592
5 GRAPHIC g307733g15n10.jpg GRAPHIC 27517
6 GRAPHIC g307733g21j11.jpg GRAPHIC 24658
7 GRAPHIC g307733g56z83.jpg GRAPHIC 16586
8 GRAPHIC g307733g57f70.jpg GRAPHIC 22487
9 GRAPHIC g307733g62k76.jpg GRAPHIC 20634
10 GRAPHIC g307733g72x19.jpg GRAPHIC 53706
11 GRAPHIC g307733g73d40.jpg GRAPHIC 114562
12 GRAPHIC g307733g79g77.jpg GRAPHIC 64504
13 GRAPHIC g307733g82b92.jpg GRAPHIC 60156
14 GRAPHIC g307733g82x90.jpg GRAPHIC 39938
15 GRAPHIC g307733g83z52.jpg GRAPHIC 33022
16 GRAPHIC g307733g87j62.jpg GRAPHIC 86454
17 GRAPHIC g307733g88j14.jpg GRAPHIC 73207
18 GRAPHIC g307733g95x17.jpg GRAPHIC 72976
  Complete submission text file 0001193125-17-114795.txt   4459500
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-36620 | Film No.: 17747606
SIC: 2834 Pharmaceutical Preparations